NPY 1 Receptors Participate in the Regulation of Myocardial Contractility in Rats

Published on Feb 27, 2017in Bulletin of Experimental Biology and Medicine0.775
· DOI :10.1007/S10517-017-3629-X
P. M. Masliuko1
Estimated H-index: 1
,
T. A. Anikina3
Estimated H-index: 3
(Kazan: Kazan Federal University)
+ 3 AuthorsTimur L. Zefirov5
Estimated H-index: 5
(Kazan: Kazan Federal University)
Sources
Abstract
: Selective agonist (Leu(31)Pro(34)NPY) and blocker (BIBP-3226) of NPY1 receptors were used to determine the type of NPY receptors involved in myocardial contraction. Experiments with isometric contraction of myocardial strips from mature rats showed that the agonist produced the most potent effect in a concentration of 10-7 M. In this concentration, Leu(31)Pro(34)NPY showed the greatest positive inotropic effect on the contraction of the atria and ventricles. In contrast, selective blocker BIBP-3226 reduced the force of myocardial contractions. Pretreatment of myocardial strips with this blocker abolished the positive inotropic effect of Leu(31)Pro(34)NPY, which attested to important role of NPY1 receptors in myocardial contraction.
📖 Papers frequently viewed together
37 Citations
14 Citations
4 Citations
References7
Newest
#1Petr M. MasliukovH-Index: 10
#2Konstantin MoiseevH-Index: 4
Last. Nozdrachev Ad (SPbU: Saint Petersburg State University)H-Index: 11
view all 6 authors...
Abstract Neuropeptide Y (NPY) plays a trophic role in the nervous and vascular systems and in cardiac hypertrophy. However, there is no report concerning the expression of NPY and its receptors in the heart during postnatal development. In the current study, immunohistochemistry and Western blot analysis was used to label NPY, and Y1R, Y2R, and Y5R receptors in the heart tissue and intramural cardiac ganglia from rats of different ages (newborn, 10 days old, 20 days old, 30 days old, 60 days old...
10 CitationsSource
#1A. A. Zverev (Kazan: Kazan Federal University)H-Index: 2
#2T. A. Anikina (Kazan: Kazan Federal University)H-Index: 3
Last. T. L. Zefi rov (Yaroslavl State Medical Academy)H-Index: 1
view all 4 authors...
We studied the effect of neuropeptide Y in concentrations of 10–10-10–6 M on myocardial contractility of rats at the age of 7, 21, and 100 days. Studying the isometric contraction of myocardial strips showed that neuropeptide Y decreases the force of myocardial contraction in 7-day-old rat pups. Exogenous neuropeptide Y produced a biphasic effect in 21-day-old rats, which was manifested in the increase and subsequent decrease in myocardial contractility. Neuropeptide Y had little effect on myoca...
3 CitationsSource
Neuropeptide Y (NPY) containing 6 amino acid residues belongs to peptides widely spread in the central and peripheral nervous system. NPY and its receptors play an extremely diverse role in the nervous system, including regulation of satiety, of emotional state, of vascular tone, and of gastrointestinal secretion. In mammals, NPY has been revealed in the majority of sympathetic ganglion neurons, in a high number of neurons of parasympathetic cranial ganglia as well as of intramural ganglia of th...
12 CitationsSource
Neuropeptide FF (NPFF) is a part of a neurotransmitter system acting as a modulator of endogenous opioid functions. At this time, no non-peptide or peptide NPFF-antagonists have been discovered. Here, we demonstrate that Neuropeptide Y (NPY) ligands, in fact possess significant ability to interact with the human NPFF2 receptors. NPY Y1 antagonist BIBP3226 and mixed Y1 antagonist/Y4 agonist GR231118 are able to displace with low aAnity, 50‐100 nM, the specific binding on NPFF receptors expressed ...
79 CitationsSource
The developmental increase in L-type Ca current ( I Ca,L) density in the rat ventricle is reproduced in vitro by culturing neonatal myocytes with sympathetic neurons. We tested whether this effect of sympathetic innervation results from a chronic or sustained action of neurally released neuropeptide Y (NPY). Ventricular myocytes from newborn rats were cultured in serum-free medium with or without sympathetic neurons, NPY, or NPY analogs. Ca currents were measured in single myocytes at room tempe...
28 CitationsSource
Neuropeptide Y (NPY) is a co-transmitter of the sympathetic nervous system including the renal nerves. The kidney expresses NPY receptors, which can also be activated by peptide YY (PYY), a circulating hormone released from gastrointestinal cells. Five subtypes of NPY receptors have been cloned, among which Y1, Y2 and Y5 appear to be involved in the regulation of renal function. NPY produces potent renal vasoconstriction in vitro in isolated interlobar arteries and in the isolated perfused kidne...
51 CitationsSource
#1Claes Wahlestedt (Lund University)H-Index: 81
#2Björn Wohlfart (Lund University)H-Index: 20
Last. Rolf Håkanson (Lund University)H-Index: 86
view all 3 authors...
Neuropeptide Y (NPY) is present in nerve fibres throughout the mammalian heart. We have elucidated the effects of NPY on the isolated papillary muscle and heart (Langendorff) from the guinea-pig. The paced papillary muscle was studied with regard to duration of the action potential, peak force, maximum rate of force development, time to peak force, and time from peak force to half relaxation; all these parameters were identical whether or not NPY (5 × 10−7 m) was present in the medium. When a st...
31 CitationsSource
Cited By6
Newest
#1A. А. Zverev (Kazan: Kazan Federal University)
#2N. V. Leonov (Kazan: Kazan Federal University)
Last. Т. L. Zefirov (Kazan: Kazan Federal University)
view all 4 authors...
We studied the effect of non-selective agonist of VIP receptors of vasoactive intestinal polypeptide in different concentrations on the frequency, force, and duration of isometric contraction of myocardial strips of the right atrium under conditions of spontaneous activity, as well as the force and duration of contractions of the right ventricle in rats. It was found that the agonist produced a positive inotropic and chronotropic effect that depended on its concentration. The maximum effect was ...
Source
#1Lejla Medzikovic (UvA: University of Amsterdam)H-Index: 4
#2Cindy P. A. A. van Roomen (UvA: University of Amsterdam)H-Index: 20
Last. Vivian de Waard (UvA: University of Amsterdam)H-Index: 23
view all 12 authors...
Aims: Cardiac remodelling and heart failure are promoted by persistent sympathetic activity. We recently reported that nuclear receptor Nur77 may protect against sympathetic agonist-induced cardiac remodelling in mice. The sympathetic co-transmitter neuropeptide Y (NPY) is co-released with catecholamines and is a known cardiac modulator and predictor of heart failure mortality. Recently, transcriptome analyses revealed NPY as a putative target of Nur77. In this study, we assess whether Nur77 mod...
8 CitationsSource
#1Rita Businaro (Sapienza University of Rome)H-Index: 18
#1Rita Businaro (Sapienza University of Rome)H-Index: 6
Last. Elena De Falco (Sapienza University of Rome)H-Index: 19
view all 14 authors...
Neuropeptide Y (NPY), a powerful neurotransmitter of the central nervous system, is a key regulator of angiogenesis and biology of adipose depots. Intriguingly, its peripheral vascular and angiogenic powerful activity is strictly associated to platelets, which are source of clinical hemoderivates, such as platelet lysate (PL), routinely employed in several clinical applications as wound healing, and to preserve ex vivo the progenitor properties of the adipose stromal cells pool. So far, the pres...
8 CitationsSource